ALLO vs PH · rev $22.0K vs P/E 28, rev $19.85B
Allogene Therapeutics Inc (ALLO) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
ALLO currently screens at market cap $258.1M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the ALLO and PH stock pages for the full models.
Not investment advice.